Marubeni expands pharmaceutical footprint across Africa, Asia, and the Middle East

Marubeni Corporation has completed its investment in Phillips Pharma, strengthening its pharmaceutical strategic platform across 26 countries and regions. The move supports the development of a new antimalarial drug in Africa and facilitates the import and distribution of high-demand medicines across the continent. Combined with existing operations in Asia and the Middle East, Marubeni aims to improve access to pharmaceuticals, enhance cross-regional collaboration, and address gaps in healthcare infrastructure. The initiative aligns with its GC2027 strategy focused on scalable, high-value growth platforms.

Read the full article here for details on Marubeni’s global pharmaceutical strategy.